Forecast Period | 2026-2030 |
Market Size (2024) | USD 35.38 Million |
CAGR (2025-2030) | 4.81% |
Fastest Growing Segment | Sample Preservation & Storage |
Largest Market | West India |
Market Size (2030) | USD 46.37 Million |
Market Overview
India
Cord Blood Banking Market was valued at USD 35.38 Million in 2024 and is
expected to reach USD 46.37 Million by 2030 with a CAGR of 4.81% during the
forecast period. The cord blood banking market in India is undergoing rapid
evolution, reflecting a growing awareness of its potential benefits and
expanding opportunities within the healthcare sector. Cord blood, which is the
blood left in the umbilical cord and placenta after childbirth, is rich in
hematopoietic stem cells that can be used for treating a range of medical
conditions, including certain cancers, genetic disorders, and blood diseases.
Private
cord blood banks have been at the forefront of this growth, offering services
to store a family’s own cord blood for personal use. These banks have seen an
uptick in demand due to the perceived value of having a readily available stem
cell source for the child or family members in case of medical emergencies. The
marketing efforts of private cord blood banks, coupled with advances in
technology, have contributed to increasing consumer confidence and interest in
these services.
Public
cord blood banks, on the other hand, focus on collecting and storing cord blood
donations for use by patients in need, irrespective of familial relations. This
model is gaining momentum due to its potential to provide life-saving
treatments to a broader patient base. Public banks are supported by government
initiatives and collaborations with healthcare institutions, further driving
their growth.
Several
factors are driving the expansion of the cord blood banking market in India.
First and foremost is the increasing awareness and education regarding the
benefits of stem cell therapy. Healthcare professionals and media campaigns
have played a crucial role in informing the public about the potential
life-saving applications of cord blood stem cells, leading to a growing number
of parents considering cord blood banking.
Despite
the positive trends, the cord blood banking market in India faces several
challenges. One of the primary issues is the high cost associated with private
cord blood banking services. The financial burden of storing cord blood can be
a deterrent for many families, particularly in a price-sensitive market like
India.
Key Market Drivers
Growing Prevalence of Autoimmune
Diseases
The
increasing prevalence of autoimmune diseases in India is emerging as a
significant driver for the country's cord blood banking market. Autoimmune
diseases, wherein the immune system mistakenly attacks the body's own tissues,
are on the rise, reflecting a broader trend observed globally. This growing
health challenge is catalyzing interest in cord blood banking due to the
potential of stem cells derived from umbilical cord blood in treating various
autoimmune conditions.
Autoimmune
diseases encompass a range of conditions where the immune system's malfunction
results in chronic inflammation and damage to healthy tissues. Common
autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis,
and type 1 diabetes. These conditions can be debilitating, requiring long-term
management and, in some cases, innovative treatments. The increasing incidence
of autoimmune diseases in India, driven by genetic, environmental, and
lifestyle factors, is creating a heightened demand for effective treatment
options.
A
report published in 2023 indicates that women in India are more susceptible to
autoimmune diseases compared to men. Autoimmune diseases occur when the immune
system mistakenly targets and attacks the body's own healthy cells and tissues,
unable to distinguish between the body's own cells and foreign entities.
Experts estimate that approximately 80% of individuals diagnosed with
autoimmune diseases are women.
Cord
blood banking, which involves collecting and storing the blood from a newborn's
umbilical cord for potential future medical use, is gaining prominence due to
its potential therapeutic benefits. Cord blood is rich in hematopoietic stem
cells, which have the ability to differentiate into various types of cells and
have shown promise in treating a range of conditions, including autoimmune
diseases. The growing recognition of the potential benefits of cord blood stem
cells is driving interest in cord blood banking as a preventive measure.
One
of the key factors influencing this trend is the increasing awareness among
expectant parents about the role of stem cells in treating autoimmune diseases.
As knowledge about the potential applications of cord blood stem cells spreads,
more families are considering cord blood banking as a safeguard against future
health issues. The ability to access a valuable source of stem cells for
potential use in treating autoimmune diseases is a compelling incentive for
many parents.
The
expanding prevalence of autoimmune diseases is prompting both private and
public cord blood banks to increase their outreach and services. Private cord
blood banks are focusing on educating potential clients about the benefits of
cord blood stem cells in treating autoimmune conditions, while public banks are
emphasizing the importance of cord blood donation for broader therapeutic use.
The
future of the cord blood banking market in India appears promising, driven by
the growing prevalence of autoimmune diseases. As the incidence of these
conditions continues to rise, the demand for stem cell therapies is expected to
increase, bolstering the cord blood banking sector. Continued advancements in
research, coupled with supportive policies and increased public awareness, will
likely drive further growth and innovation in the market.
Increased Number of Hospitals
and Clinics Offering Cord Blood Banking
One of the most notable trends in the Indian healthcare sector
is the integration of cord blood banking into routine childbirth services.
Hospitals and clinics across the country are increasingly incorporating cord
blood banking as part of their standard delivery packages. This integration
ensures that expectant parents are presented with the option of cord blood
banking at a crucial decision-making point, thereby increasing the likelihood
of its adoption. The convenience of having cord blood banking services
available at the point of delivery removes barriers related to awareness and
accessibility, making it easier for families to choose this service.
The expansion of healthcare facilities in India has played a
crucial role in the proliferation of cord blood banking services. As the
healthcare infrastructure improves and more hospitals and clinics are
established, there is a corresponding increase in the availability of
specialized services such as cord blood banking. This expansion is particularly
evident in tier-2 and tier-3 cities, where previously such services were
limited. By extending cord blood banking services beyond major metropolitan
areas, healthcare providers are catering to a larger and more diverse
population, thus driving market growth.
Currently, India's healthcare infrastructure is extensive,
spanning from primary healthcare centers to advanced tertiary care hospitals.
As one of the largest healthcare systems globally, it is projected to expand to
USD 50 billion by 2033, fueled by rising investments from both public and
private sectors. Presently, developers are partnering with healthcare providers
to establish state-of-the-art facilities in metropolitan areas as well as tier
2 and tier 3 cities, thereby broadening access to high-quality healthcare for a
greater segment of the population.
The growing number of hospitals and clinics offering cord
blood banking has led to the development of comprehensive service packages that
include not only the collection and storage of cord blood but also detailed
consultation services for expectant parents. These packages often include
educational resources, risk assessments, and customized plans based on
individual family needs. By providing a more holistic service experience,
healthcare providers are increasing the appeal of cord blood banking and
encouraging more families to opt for it.
According to a report published by the Ministry of Health and
Family Welfare in 2022, India has 3,840 licensed blood banks across the
country. The Government of India, through the National Health Mission, aids
States and Union Territories in enhancing their healthcare systems, which
includes strengthening existing blood banks and establishing new ones.
Additionally, the Blood Transfusion Services support 1,131 public and
charitable sector blood banks by providing resources such as manpower, blood
bags, testing kits, and organizing voluntary blood donation (VBD) camps and
information, education, and communication (IEC) activities. The government also
supplies mobile vans for blood collection and transportation to various States and
Union Territories.
The availability of cord blood banking services in a wider
range of healthcare facilities has a direct impact on patient decision-making.
When expectant parents have easy access to information and services related to
cord blood banking during their prenatal visits or hospital stays, they are
more likely to make informed decisions about banking their child’s cord blood.
The presence of these services in trusted healthcare settings reassures parents
and underscores the importance of cord blood as a valuable resource for
potential future medical treatments.
Download Free Sample Report
Key Market Challenges
High Cost Associated with Cord
Blood Banking
Cord
blood banking represents a significant advancement in medical science, offering
the potential for life-saving treatments through stem cell therapies. However,
one of the most formidable challenges facing the cord blood banking industry in
India is the high cost associated with this service. This financial barrier
impacts both market growth and accessibility, posing a challenge to broader
adoption of cord blood banking in the country.
The
process of cord blood banking involves several stages, including collection,
processing, and storage, each of which incurs substantial costs. Initially, the
collection of cord blood requires specialized medical personnel and equipment.
This step involves extracting blood from the umbilical cord immediately after
birth, a procedure that must be conducted under sterile conditions to ensure
the viability of the stem cells. The need for trained professionals and sterile
equipment contributes to the high costs of the initial collection.
Following
collection, the cord blood undergoes a complex processing procedure designed to
isolate and preserve the stem cells. This step involves sophisticated
laboratory techniques and state-of-the-art technology to ensure the cells
remain viable for future use. The processing stage is both labor-intensive and
technically demanding, requiring significant investment in advanced technology
and skilled personnel.
Once
processed, the cord blood must be stored in cryogenic conditions to maintain
its integrity over time. This long-term storage involves maintaining extremely
low temperatures in specialized cryogenic tanks, which requires continuous
monitoring and maintenance. The infrastructure necessary for this storage, such
as temperature-controlled environments and backup power systems adds further to
the overall cost.
For
many families, these costs translate into a significant financial burden. According
to a report published by Kauvery Hospital, many parents are interested in
banking their babies' cord blood to protect their families' health. As a
result, most cord blood banks charge an upfront fee covering collection, processing,
and cryopreservation. For example, some banks may charge around USD 1,191.09,
which includes the cost of the collection kit and transportation of the cord
blood. Additionally, there is an annual storage fee of approximately USD
714.65. For a substantial portion of the population, these expenses are
prohibitive, especially when viewed in the context of India’s diverse economic
landscape. High costs create a barrier for many potential clients, limiting
access to this potentially life-saving service and hindering widespread
adoption.
Key Market Trends
Growth of Stem Cell Research
The
Indian cord blood banking market is undergoing a significant transformation,
largely driven by the rapid advancement of stem cell research. This burgeoning
field is reshaping the landscape of cord blood banking in India, creating new
opportunities and driving market growth. As scientific understanding and
technological capabilities in stem cell research expand, they are bringing
renewed attention and investment to cord blood banking, highlighting its
crucial role in the future of medical treatment and healthcare.
Stem
cell research has made remarkable strides in recent years, showcasing the vast
potential of stem cells in regenerative medicine and the treatment of a variety
of diseases. Stem cells, particularly those derived from umbilical cord blood,
have shown promise in treating conditions such as leukemia, lymphoma, and
certain genetic disorders. This potential has generated increased interest
among researchers, healthcare providers, and prospective parents in the
importance of cord blood banking.
In
February 2022, the Government of India advanced stem cell research by
leveraging various departments and institutions. This effort included support
for both fundamental and clinical research through national funding agencies
such as the Indian Council of Medical Research (ICMR), the Department of
Biotechnology (DBT), and the Department of Science and Technology (DST). These
initiatives have led to the development of cutting-edge infrastructure at more
than 40 leading health research and educational institutions, as well as
bolstering industry efforts within India.
In
India, the growth of stem cell research is directly influencing the cord blood
banking market. The country’s investment in cutting-edge research and
development is leading to the discovery of new therapeutic applications for
stem cells. As clinical trials advance and demonstrate the efficacy of stem
cell treatments, the demand for stored cord blood is anticipated to rise. This
growing demand is prompting more parents to consider cord blood banking as a
proactive measure for their children’s future health.
Several
factors are contributing to the increased emphasis on stem cell research in
India. Firstly, the Indian government and private sector are investing heavily
in biotechnology and healthcare infrastructure. Research institutions and
biotech firms are focusing on the development of advanced stem cell therapies,
supported by both public funding and private investment. This investment is
crucial in fostering innovation and translating research findings into viable
treatments.
Moreover,
partnerships between Indian cord blood banks and research institutions are
strengthening the sector. These collaborations facilitate access to
state-of-the-art research and technologies, ensuring that cord blood banks are
equipped to handle and preserve stem cells at the highest standards. Such
partnerships also enhance the credibility and appeal of cord blood banking services,
as they align with the latest advancements in stem cell research.
Segmental Insights
Service Insights
Based
on Service, Sample Preservation & Storage have emerged as the fastest
growing segment in the India Cord Blood Banking Market in 2024. Effective
preservation and storage of cord blood samples are crucial due to the unique
nature of stem cells and their use in future medical treatments. Once
collected, cord blood must be processed and stored under highly controlled
conditions to ensure the viability of stem cells for potential therapeutic use.
The process involves several critical steps: collection, processing,
cryopreservation, and long-term storage. Each step must be meticulously managed
to maintain the quality and potency of the stem cells, which can significantly
impact their effectiveness in future treatments.
The
growth of the cord blood banking market in India reflects an increasing
understanding of the long-term benefits of preserving high-quality stem cell
samples. Advances in cryopreservation technology have improved the ability to
maintain stem cells in a viable state over extended periods, enhancing the
market's attractiveness. As a result, parents are increasingly recognizing the
value of investing in cord blood banking for potential future medical needs,
driving demand for reliable preservation and storage solutions.
Technological
advancements in cryopreservation and storage techniques are a key driver behind
the growing emphasis on sample preservation in the Indian cord blood banking
market. Innovations in freezing methods, such as controlled-rate freezing and
vitrification, have significantly improved the efficiency and effectiveness of
stem cell preservation. These technologies ensure that stem cells remain viable
and functional, even after years of storage.
The
development of sophisticated storage systems that maintain optimal temperatures
and conditions for cord blood samples is also contributing to market growth.
Advanced storage facilities equipped with state-of-the-art freezers and
monitoring systems provide an added layer of assurance for parents investing in
cord blood banking. The ability to offer long-term storage with high levels of
reliability and security is becoming a competitive advantage for cord blood banks
in India.
Component Insights
Based
on Component, Cord Blood have emerged as the dominating segment in the India
Cord Blood Banking Market during the forecast period. One of the primary
drivers behind the dominance of cord blood banking in India is the increasing
awareness and education surrounding its benefits. Over recent years, public
awareness campaigns and educational initiatives have played a crucial role in
informing expectant parents about the value of cord blood. This increased
knowledge has highlighted the potential of stem cells for treating a range of
medical conditions, including certain cancers, genetic disorders, and
autoimmune diseases. As parents become more informed about the long-term health
benefits and the potential to use cord blood for future medical treatments,
they are more likely to invest in cord blood banking services.
The
advancement of medical research and technology has significantly contributed to
the prominence of cord blood banking. Research has continually expanded the
range of diseases and conditions that can be treated using stem cells derived
from cord blood. Breakthroughs in stem cell therapies and clinical trials have
demonstrated the potential of cord blood in regenerative medicine, leading to
increased demand for these services. As medical science progresses, the range
of applications for cord blood stem cells continues to grow, reinforcing its
importance and appeal to prospective parents.
Supportive
regulatory frameworks and government policies have also played a pivotal role
in the growth of the cord blood banking market. The Indian government has
introduced regulations and guidelines to ensure the quality and safety of cord
blood banking services. These regulatory measures help build consumer
confidence and ensure that cord blood banks adhere to high standards of
practice. Additionally, government-backed health programs and incentives that
promote stem cell research and cord blood banking contribute to the expansion
of the market.
The
increased availability and accessibility of cord blood banking services across
India have been instrumental in driving market dominance. The rise in the
number of hospitals and clinics offering cord blood banking as part of their
childbirth packages has made these services more accessible to a broader
segment of the population. By integrating cord blood banking into routine
healthcare services, healthcare providers facilitate easier decision-making for
expectant parents, thereby boosting adoption rates.
Download Free Sample Report
Regional Insights
Based
on Region, West India have emerged as the dominating region in the India Cord
Blood Banking Market in 2024. One of the primary drivers of West India's
prominence in the cord blood banking sector is its well-developed healthcare
infrastructure. The region, particularly Maharashtra and Gujarat, is home to a
significant number of advanced medical facilities and institutions. Cities such
as Mumbai and Pune in Maharashtra, and Ahmedabad and Surat in Gujarat, boast
state-of-the-art hospitals and specialized healthcare centers that are equipped
with the necessary technology and expertise for cord blood collection and
processing. The presence of these high-quality medical facilities provides a
strong foundation for the growth and development of cord blood banking
services.
Furthermore,
West India benefits from a high concentration of affluent and educated families
who are more likely to invest in advanced medical services, including cord
blood banking. The region's economic prosperity has led to an increased focus
on healthcare and preventive measures, with many families seeking to safeguard
their health through the use of innovative technologies. This economic
advantage translates into higher demand for cord blood banking services,
driving the growth of the market in West India.
The
region has also seen a significant rise in public awareness and education
regarding the benefits of cord blood banking. Healthcare providers and cord
blood banks in West India have undertaken extensive educational campaigns to
inform expectant parents about the potential life-saving advantages of storing
cord blood stem cells. Increased awareness and understanding of the value of
cord blood for treating various diseases have led to higher adoption rates
among families in West India.
Additionally,
West India’s strategic geographic location enhances its position in the cord
blood banking market. The region’s well-connected transport and logistics
networks facilitate the efficient collection, processing, and storage of cord
blood. Major cities in West India have access to advanced transportation
infrastructure, including airports and ports, which ensures that cord blood can
be quickly and safely transported to processing facilities. This logistical
efficiency is crucial for maintaining the viability of the cord blood stem
cells and ensuring timely delivery.
Recent Development
- In
October 2023, Cordlife Group Limited, listed on the Singapore Exchange,
announced that its Indian subsidiary, Cordlife Sciences India Pvt Ltd, has
inaugurated a pioneering diagnostic laboratory in central Kolkata. This new
facility is designed to serve as a testing hub for Cordlife India, addressing
the healthcare needs of the company’s existing stem cell banking clients and
their families, as well as nearby patients, healthcare partners, and
physicians.
- In
November 2023, LifeCell, India’s largest and most accredited stem cell banking
company, introduced a groundbreaking stem cell banking solution at the world’s
most affordable price. Umbilical cord blood stem cells, which have been used in
over 30,000 successful transplants worldwide over the past 25 years, are
central to this new offering. This launch coincides with the global observance
of the 25th anniversary of umbilical cord blood stem cell treatments.
- In
August 2024, LifeCell, a leading name in stem cell banking, diagnostics,
genetic testing, and pre-conception care in India, is set to revolutionize
mother-baby skincare with the launch of AreoVeda. This innovative product line
is tailored for pregnant women, new mothers, and newborns, meeting the highest
standards of purity, potency, and safety. By harnessing the regenerative
properties of natural ingredients, LifeCell provides a scientifically-backed
approach to clean skincare, setting new benchmarks in the industry.
Key Market Players
- Cryoviva
Biotech Pvt. Ltd.
- LifeCell
International Pvt Ltd.
- Cordlife
Sciences India Pvt Ltd.
- Regrow
Biosciences Pvt. Ltd.
- ReeLabs
Pvt. Ltd.
- StemCyte
India Therapeutics Pvt. Ltd.
- Reliance
Life Sciences Pvt. Ltd./India.
|
By
Service
|
By
Component
|
By
Application
|
By
Sector
|
By
Region
|
- Sample
Preservation & Storage
- Sample
Analysis
- Sample
Processing
- Sample
Collection & Transportation
|
|
- Cancer Disease
- Diabetes
- Blood Disease
- Immune Disorders
- Metabolic Disorders
- Others
|
- Public Cord Blood Banks
- Private cord Blood Banks
|
- North
India
- East
India
- West
India
- South
India
|
Report Scope
In this report, the India Cord Blood Banking Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- India Cord Blood Banking Market, By Service:
o Sample Preservation & Storage
o Sample Analysis
o Sample Processing
o Sample Collection & Transportation
- India Cord Blood Banking Market, By Component:
o Cord Blood
o Cord Tissue
- India Cord Blood Banking Market, By Application:
o Cancer Disease
o Diabetes
o Blood Disease
o Immune Disorders
o Metabolic Disorders
o Others
- India Cord Blood Banking Market, By Sector:
o Public Cord Blood Banks
o Private cord Blood Banks
- India Cord Blood Banking Market, By Region:
o North India
o East India
o West India
o South India
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the India Cord
Blood Banking Market.
Available Customizations:
India Cord Blood Banking Market report with the
given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
India Cord Blood
Banking Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at
[email protected]